| Typicality: | 0.396 |
| Saliency: | 0.190 |
| for use in the eu | 5 | purpose |
| medicine → be developed by → pharmaceutical companies | 6 |
| medicine → be manufactured by → pharmaceutical company | 3 |
| negative | neutral | positive |
| 0.069 | 0.881 | 0.050 |
| Raw frequency | 9 |
| Normalized frequency | 0.190 |
| Modifier score | 0.700 |
| Perplexity | 30.510 |